The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.
Open accessAbstract
In late 1994 and early 1995, Ebola (EBO) virus dramatically reemerged in Africa, causing human disease in the Ivory Coast and Zaire. Analysis of the entire glycoprotein genes of these viruses and those of other EBO virus subtypes has shown that the virion glycoprotein (130 kDa) is encoded in two reading frames, which are linked by transcriptional editing. This editing results in the addition of an extra nontemplated adenosine within a run of seven adenosines near the middle of the coding region. The primary gene product is a smaller (50-70 kDa), nonstructural, secreted glycoprotein, which is produced in large amounts and has an unknown function. Phylogenetic analysis indicates that EBO virus subtypes are genetically diverse and that the recent Ivory Coast isolate represents a new (fourth) subtype of EBO virus. In contrast, the EBO virus isolate from the 1995 outbreak in Kikwit, Zaire, is virtually identical to the virus that caused a similar epidemic in Yambuku, Zaire, almost 20 years earlier. This genetic stability may indicate that EBO viruses have coevolved with their natural reservoirs and do not change appreciably in the wild.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A simple and very efficient method for generating cDNA libraries
Gubler, U., & Hoffman, B. J. (1983) · Gene · doi:10.1016/0378-1119(83)90230-5 · Cited by 4,510
Preliminary report: isolation of Ebola virus from monkeys imported to USA
Jahrling, P. B., Geisbert, T. W., Johnson, E. D., Peters, C. J., Dalgard, D. W., & Hall, W. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)90737-p · Cited by 403
Self-citationIsolation and partial characterisation of a new strain of Ebola virus
Le Guenno, B., Formenty, P., Wyers, M., Gounon, P., Walker, F., & Boesch, C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90925-7 · Cited by 402
Sanchez, A., Kiley, M. P., Holloway, B. P., & Auperin, D. D. (1993) · Virus Research · doi:10.1016/0168-1702(93)90063-s · Cited by 318
Self-citationChambers, P., Pringle, C. R., & Easton, A. J. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-12-3075 · Cited by 299
Ribosomal frameshifting on viral RNAs
Brierley, I. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-8-1885 · Cited by 263
Molecular biology and evolution of filoviruses
Feldmann, H., Klenk, H.-D., & Sanchez, A. (1993) · Archives of Virology · doi:10.1007/978-3-7091-9300-6_8 · Cited by 159
Self-citationVolchkov, V. E., Blinov, V. M., & Sv, N. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80662-z · Cited by 122
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein
Will, C., Mühlberger, E., Linder, D., Slenczka, W., Klenk, H., & Feldmann, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1203-1210.1993 · Cited by 80
Cited by
Feldmann, H., & Geisbert, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,374
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
Gire, S. K., Goba, A., Andersen, K. G., Sealfon, R. S. G., Park, D. J., Kanneh, L., Jalloh, S., Momoh, M., Fullah, M., Dudas, G., et al. (2014) · Science · doi:10.1126/science.1259657 · Cited by 1,215
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., & Saphire, E. O. (2008) · Nature · doi:10.1038/nature07082 · Cited by 736
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
Jones, S. M., Feldmann, H., Ströher, U., Geisbert, J. B., Fernando, L., Grolla, A., Klenk, H.-D., Sullivan, N. J., Volchkov, V. E., Fritz, E. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1258 · Cited by 687
Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer, D. A. (1999) · Virology · doi:10.1006/viro.1999.9716 · Cited by 663
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
Self-citationPathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576
A system for functional analysis of Ebola virus glycoprotein
Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., & Kawaoka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14764 · Cited by 575
Self-citationOrigin and Evolution of Viruses
Holland, J., & Domingo, E. (1998) · Virus Genes · doi:10.1023/a:1007989407305 · Cited by 520
Towner, J. S., Rollin, P. E., Bausch, D. G., Sanchez, A., Crary, S. M., Vincent, M., Lee, W. F., Spiropoulou, C. F., Ksiazek, T. G., Lukwiya, M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4330-4341.2004 · Cited by 515
Self-citationFUNCTIONS AND MECHANISMS OF RNA EDITING
Gott, J. M., & Emeson, R. B. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.499 · Cited by 512
Processing of the Ebola virus glycoprotein by the proprotein convertase furin
Volchkov, V. E., Feldmann, H., Volchkova, V. A., & Klenk, H.-D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5762 · Cited by 497
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492
Mühlberger, E., Weik, M., Volchkov, V. E., Klenk, H.-D., & Becker, S. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2333-2342.1999 · Cited by 486
The Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478
Kuhn, J. H., Becker, S., Ebihara, H., Geisbert, T. W., Johnson, K. M., Kawaoka, Y., Lipkin, W. I., Negredo, A. I., Netesov, S. V., Nichol, S. T., et al. (2010) · Archives of Virology · doi:10.1007/s00705-010-0814-x · Cited by 470
Self-citationNon-canonical translation in RNA viruses
Firth, A. E., & Brierley, I. (2012) · Journal of General Virology · doi:10.1099/vir.0.042499-0 · Cited by 468
Bwaka, M. A., Bonnet, M., Calain, P., Colebunders, R., De Roo, A., Guimard, Y., Katwiki, K. R., Kibadi, K., Kipasa, M. A., Kuvula, K. J., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514308 · Cited by 465
Self-citationThe Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995
Khan, A. S., Tshioko, F. K., Heymann, D. L., Le Guenno, B., Nabeth, P., Kerstiëns, B., Fleerackers, Y., Kilmarx, P. H., Rodier, G. R., Nkuku, O., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514306 · Cited by 463
Self-citationEpitopes Involved in Antibody-Mediated Protection from Ebola Virus
Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L., & Hart, M. K. (2000) · Science · doi:10.1126/science.287.5458.1664 · Cited by 459
Discovery of an Ebolavirus-Like Filovirus in Europe
Negredo, A., Palacios, G., Vázquez-Morón, S., González, F., Dopazo, H., Molero, F., Juste, J., Quetglas, J., Savji, N., de la Cruz Martínez, M., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002304 · Cited by 431
Human asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411
Weissenhorn, W., Carfí, A., Lee, K.-H., Skehel, J. J., & Wiley, D. C. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80159-8 · Cited by 391
Garbutt, M., Liebscher, R., Wahl-Jensen, V., Jones, S., Möller, P., Wagner, R., Volchkov, V., Klenk, H.-D., Feldmann, H., & Ströher, U. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5458-5465.2004 · Cited by 381
Inflammatory responses in Ebola virus-infected patients
BAIZE, S., LEROY, E. M., GEORGES, A. J., GEORGES-COURBOT, M.-C., CAPRON, M., BEDJABAGA, I., LANSOUD-SOUKATE, J., & MAVOUNGOU, E. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01800.x · Cited by 370
Olinger, G. G., Pettitt, J., Kim, D., Working, C., Bohorov, O., Bratcher, B., Hiatt, E., Hume, S. D., Johnson, A. K., Morton, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213709109 · Cited by 366
Wool-Lewis, R. J., & Bates, P. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3155-3160.1998 · Cited by 357
Atkins, J. F., Loughran, G., Bhatt, P. R., Firth, A. E., & Baranov, P. V. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw530 · Cited by 324
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
Martines, R. B., Ng, D. L., Greer, P. W., Rollin, P. E., & Zaki, S. R. (2015) · The Journal of Pathology · doi:10.1002/path.4456 · Cited by 319
The evolution of Ebola virus: Insights from the 2013-2016 epidemic
Holmes, E. C., Dudas, G., Rambaut, A., & Andersen, K. G. (2016) · Nature · doi:10.1038/nature19790 · Cited by 314
Rodriguez, L. L., De Roo, A., Guimard, Y., Trappier, S. G., Sanchez, A., Bressler, D., Williams, A. J., Rowe, A. K., Bertolli, J., Khan, A. S., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514291 · Cited by 311
Self-citationEbola virus: from discovery to vaccine
Feldmann, H., Jones, S., Klenk, H.-D., & Schnittler, H.-J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1154 · Cited by 308
Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs
Connolly, B. M., Steele, K. E., Davis, K. J., Geisbert, T. W., Kell, W. M., Jaax, N. K., & Jahrling, P. B. (1999) · The Journal of Infectious Diseases · doi:10.1086/514305 · Cited by 308
Volchkov, V. E., Volchkova, V. A., Mühlberger, E., Kolesnikova, L. V., Weik, M., Dolnik, O., & Klenk, H.-D. (2001) · Science · doi:10.1126/science.1057269 · Cited by 303
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection
Maruyama, T., Rodriguez, L. L., Jahrling, P. B., Sanchez, A., Khan, A. S., Nichol, S. T., Peters, C. J., Parren, P. W. H. I., & Burton, D. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6024-6030.1999 · Cited by 293
Self-citationEbola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer
Jasenosky, L. D., Neumann, G., Lukashevich, I., & Kawaoka, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5205-5214.2001 · Cited by 286
Ebolavirus Glycoprotein Structure and Mechanism of Entry
Lee, J. E., & Saphire, E. O. (2009) · Future Virology · doi:10.2217/fvl.09.56 · Cited by 281
Forty-Five Years of Marburg Virus Research
Brauburger, K., Hume, A. J., Mühlberger, E., & Olejnik, J. (2012) · Viruses · doi:10.3390/v4101878 · Cited by 268
Distinct Cellular Interactions of Secreted and Transmembrane Ebola Virus Glycoproteins
Yang, Z.-Y., Delgado, R., Xu, L., Todd, R. F., Nabel, E. G., Sanchez, A., & Nabel, G. J. (1998) · Science · doi:10.1126/science.279.5353.1034 · Cited by 261
Self-citationCore structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Å resolution
Malashkevich, V. N., Schneider, B. J., McNally, M. L., Milhollen, M. A., Pang, J. X., & Kim, P. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2662 · Cited by 261
An Introduction to Ebola: The Virus and the Disease
Peters, C. J., & LeDuc, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514322 · Cited by 260
Self-citationCovalent Modifications of the Ebola Virus Glycoprotein
Jeffers, S. A., Sanders, D. A., & Sanchez, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12463-12472.2002 · Cited by 253
Self-citationSaphire, E. O., Schendel, S. L., Fusco, M. L., Gangavarapu, K., Gunn, B. M., Wec, A. Z., Halfmann, P. J., Brannan, J. M., Herbert, A. S., Qiu, X., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.033 · Cited by 212
“During Ebola virus infection the primary product of the GP gene is secreted GP (sGP), a soluble dimer that lacks GP2 and the mucin-like domain, but shares 295 amino acids of GP1 (Sanchez et al., 1996).”
Purifying selection can obscure the ancient age of viral lineages
Wertheim, J. O., & Kosakovsky Pond, S. L. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr170 · Cited by 200
The origin and evolution of Ebola and Marburg viruses
Suzuki, Y., & Gojobori, T. (1997) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a025820 · Cited by 108
Baranov, P. V., Hammer, A. W., Zhou, J., Gesteland, R. F., & Atkins, J. F. (2005) · Genome Biology · doi:10.1186/gb-2005-6-3-r25 · Cited by 67
Evaluation of ViroCyt® Virus Counter for rapid filovirus quantitation
Rossi, C., Kearney, B., Olschner, S., Williams, P., Robinson, C., Heinrich, M., Zovanyi, A., Ingram, M., Norwood, D., & Schoepp, R. (2015) · Viruses · doi:10.3390/v7030857 · Cited by 46
Relaxed selection and the evolution of RNA virus mucin-like pathogenicity factors
Wertheim, J. O., & Worobey, M. (2009) · Journal of Virology · doi:10.1128/jvi.02358-08 · Cited by 20
Metadata
- Authors
- Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J., & Nichol, S. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-04-16
- Volume
- 93
- Issue
- 8
- Pages
- 3602-3607
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1978996068
- Cited by
- 552
- References
- 13
- FWCI
- 23.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.